Fluorouracil Injection, Solution
NDC Package 16729-276-68
Package Information
Fluorouracil injection is fluorouracil is used to treat various types of cancer. This formulation utilizes a injection, solution delivery system. Marketed by Accord Healthcare, Inc., this product is identified by NDC 16729-276 and is authorized under FDA application ANDA040798.
Identification & Billing
- RxCUI: 1791701 - fluorouracil 500 MG in 10 ML Injection
- RxCUI: 1791701 - 10 ML fluorouracil 50 MG/ML Injection
- RxCUI: 1791701 - 10 ML 5-5-fluorouracil 50 MG/ML Injection
- RxCUI: 1791701 - 10 ML 5-FU 50 MG/ML Injection
- RxCUI: 1791701 - fluorouracil 500 MG per 10 ML Injection
Clinical Specifications
- Intravenous - Administration within or into a vein or veins.
- Intravenous - Administration within or into a vein or veins.
Regulatory & Marketing
Hierarchy Structure
- 16729 - Accord Healthcare, Inc.
- 16729-276 - Fluorouracil
- 16729-276-68 - 10 VIAL in 1 CARTON / 10 mL in 1 VIAL (16729-276-03)
- 16729-276 - Fluorouracil
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (16729-276). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 16729-276-68 identifies a specific commercial package of 10 vial in 1 carton / 10 ml in 1 vial (16729-276-03) of Fluorouracil, a human prescription drug labeled by Accord Healthcare, Inc.. This injection, solution is formulated for intravenous use and contains fluorouracil as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Accord Healthcare, Inc. on March 14, 2014. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Fluorouracil is used to treat various types of cancer. It is a chemotherapy drug that is used to slow or stop cancer cell growth. You should be tested for a DPD enzyme deficiency before you start treatment with fluorouracil. Ask your doctor for more details.
How is this Accord Healthcare, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 16729027668. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.